Normal view MARC view ISBD view

New challenges for HDL-modifying therapies as a strategy to lower cardiovascular disease events in statin-treated patients.

New challenges for HDL-modifying therapies as a strategy to lower cardiovascular disease events in statin-treated patients. - 2015

English

ISSN: 1573-7241

Subjects--Topical Terms:
*ATP Binding Cassette Transporter 1/me [Metabolism]
*Cholesterol/me [Metabolism]
*Hydroxymethylglutaryl-CoA Reductase Inhibitors/pd [Pharmacology]
*Lipoproteins, HDL/me [Metabolism]
*MicroRNAs/me [Metabolism]
*Simvastatin/pd [Pharmacology]
Animals
Humans

Subjects--Geographic Terms:
MedStar Heart & Vascular Institute

Index Terms--Function:
Comment
Editorial

Print
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)